SYNARC to Attend the American Society for Bone and Mineral Research (ASBMR)

Newark, CA – August 26, 2011 – SYNARC, the world’s leading provider of medical imaging services for the pharmaceutical, biotechnology, and medical device industries, announced today that Thomas Fuerst Ph.D.,  Chief Science Officer, and Klaus Engelke Ph.D., Senior Scientist, will be presenting at the American Society for Bone and Mineral Research (ASBMR)  conference in San Diego, California September 16th to 20th. The presentations topics and times are listed below.
SYNARC has extensive expertise in osteoporosis imaging services, including dual-energy X-ray absorptiometry (DXA), quantitative computed tomography (QCT), hip structural analysis (HSA), trabecular micro architecture, and vertebral fracture assessment.  SYNARC’s in-house medical directors and scientific experts are the leading authorities in the use of medical imaging and biochemical markers, and have helped develop many methods currently used in clinical trials for osteoporosis.

Date: Sunday September 18, 2011

Presentation Number:  [1128]
Location:  Room 31ABC - San Diego Convention Center
Presentation Time:  2:30 PM
Title:  Patterns of Prevalent and Incident Vertebral Fracture in the Spine: Differentiating Prevalent Fracture from Deformity
Speaker/Authors:  Thomas Fuerst

Presentation Number:  [1135]
Location:  Room 20BCD - San Diego Convention Center
Presentation Time:  2:45 PM
Title:  Effects of the Cathepsin K Inhibitor, ONO-5334, on BMD as Measured by 3D QCT in the Hip and the Spine After 2 Years of Treatment
Speaker/Authors:  Klaus Engelke

About the American Society for Bone and Mineral Research

The American Society for Bone and Mineral Research (ASBMR) represents over 4,000 clinical and experimental scientists involved in the study of bone and mineral metabolism.  For the last 30 years, ASBMR has provided a monthly publication of the Journal of Bone and Mineral Research which is the premier journal in the field. Furthermore, annually ASBMR organizes a conference to discuss the latest research and concepts of bone and mineral research, by most innovative thinkers in the field.

About CCBR-SYNARC

CCBR-SYNARC’s medical image analysis, biochemical marker, and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. CCBR-SYNARC has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas.  Our services integrate critical aspects of clinical trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients.  Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today’s clinical trials.

# # #
Contact:
Thomas Fuerst, Ph.D.
Chief Science Officer
+1 (415) 817-8911
thomas.fuerst@synarc.com